ANNALS OF ONCOLOGY, cilt.15, sa.4, ss.653-660, 2004 (SCI-Expanded, Scopus)
Background: Hematopoetic stem cell transplants (HSCT) are discussed as treatment options for patients with solid tumors. Transplant numbers have changed substantially over the last decade, few controlled studies are available and different opinions prevail. Objective information on current practice is needed.